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Erasmus Hospital, Brussels, BelgiumBackground. For the quantification of critical limb ischaemia (CLI) most vascular surgery units use sphygmo-manometric
and transcutaneous oxygen pressure (TcPO2) measurements. However, measurements obtained by cuff-manometry can be
overestimated especially in diabetic patients because of medial calcification that makes leg arteries less compressible. TcPO2
measurements present a considerable overlap in the values obtained for patients with different degrees of ischaemia and its
reproducibility has been questioned. Arterial wall stiffness has less influence on the pole test, based on hydrostatic pressure
derived by leg elevation, and this test seems to provide a reliable index of CLI.
Objective. The objective of this study was to evaluate the pole pressure test for detection of critical lower limb ischaemia,
correlating results with cuff-manometry and transcutaneous oxygen pressure.
Design. University hospital-prospective study.
Materials and methods. Seventy-four patients (83 legs) with rest pain or gangrene were evaluated by four methods: pole
test, cuff-manometry, TcPO2 and arteriography. CLI was present if the following criteria were met: (a) important
arteriographic lesionsCrest pain with an ankle systolic pressure (ASP) %40 mmHg and/or a TcPO2 %30 mmHg, or (b)
important arteriographic lesionsCtissue loss with an ASP %60 mmHg and/or a TcPO2 %40 mmHg. Fifty-seven lower
limbs met the criteria for CLI.
Results. Measurements obtained by cuff-manometry were significantly higher to those obtained by pole test (mean pressure
difference: 40 mmHg, p!0.001). The difference between the two methods remained statistically significant for both diabetics
(50.73, p!0.001) and non-diabetics (31.46, p!0.001). Mean TcPO2 value was 15.51 mmHg and there was no important
difference between patients with and without diabetes. Overall, there was a correlation between sphygmomanometry and
pole test (rZ0.481). The correlation persisted for patients without diabetes (rZ0.581), but was not evident in patients with
diabetes. Correlation between pole test and TcPO2 was observed only for patients with diabetes (rZ0.444). There was no
correlation between cuff-manometry and TcPO2. The pole test offered an accuracy of 88% for the detection of CLI. The
sensitivity of this test was 95% and the specificity 73%.Keywords: Pole test; Critical leg ischaemia.Introduction
Accurate assessment of the severity of lower limb
ischaemia is necessary for the selection of patients
requiring a surgical treatment. This is particularly
important in case of critical ischaemia where adequate
revascularisation can prevent a major amputation and
where unnecessary aggressive treatment can lead to
poor prognosis.
The quantification of critical leg ischaemia (CLI) has
been discussed widely. The second European con-
sensus document1 proposed an objective assessmenting author. Dr Nikolaos Paraskevas, MD, Department
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0253 + 05 $35.00/0 q 2005 Elsevier Ltd. All rights reserof ankle systolic pressure (ASP) %50 mmHg, or a toe
pressure (TP) %30 mmHg.
Rutherford2 proposed different cut-off values and in
addition recommends the use of the transcutaneous
measurement of oxygen tension (TcPO2).
3
It is recognized that sphygmomanometry measure-
ments can overestimate pressures, especially in
diabetics4,5 because of the medial calcification that
makes leg’s arteries less compressible. It has been
suggested that the systolic pressure at the toe level is
more accurate, as smaller vessels are easier to
compress6 but this technique gives poor results at
low temperatures7 and is difficult to use when ulcers
and gangrene are present. The measurement of TcPO2
appears reproducible and correlates well with the
existence of skin ischaemia and the FontaineEur J Vasc Endovasc Surg 31, 253–257 (2006)
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also is useful in predicting the need for amputation in
severe ischaemia.11 However, there is a considerable
overlap in the values obtained for patients with
different degrees of ischaemia,12 and the repro-
ducibility of TcPO2 has been questioned.
13,14 More-
over, technical problems with measurements are
common.
The introduction of an alternative approach, the
pole test,15 using hydrostatic pressure derived by leg
elevation, seems to provide a reliable index of severe
leg ischaemia as it is less influenced by the degree of
artery compressibility; nevertheless this test is not yet
included in any definition of CLI and it is not used
routinely in most vascular surgery units, despite of its
simplicity.
The aim of this prospective study was to evaluate
the pole pressure test by correlating it with cuff-
manometry and TcPO2 measurements and to investi-
gate the ability of this test to detect critical lower limb
ischaemia.Materials and Methods
From January 1999 to September 2000, 74 consecutive
patients (83 legs) with clinical signs of critical
ischaemia were referred to our vascular surgery unit,
for evaluation of lower limb arterial disease. All
patients were evaluated by four methods: pole test
(P), cuff-manometry (S), TcPO2 (T) and arteriography
(A).
Critical limb ischaemia (CLI) was diagnosed when
the following criteria were met:
Arteriographic evidence of at least two level lesions
(stenosis O70% or occlusion) and/or important
lesions of the three calf arteries without important
collateral development, together with either (i) persis-
tently recurring ischaemic rest pain requiring regular
adequate analgesia for more than 2 weeks, with an
ankle systolic pressure %40 mmHg and/or TcPO2
%30 mmHg or (ii) ulceration or gangrene of the foot or
toes, with an ankle systolic pressure %60 mmHg
and/or TcPO2 %40 mmHg.
Fifty-seven legs met the inclusion criteria for CLI.Measurement by TcPO2
This test was performed first, in the supine position.
The electrode was placed on the dorsum of the foot (or
nearest to an ulcer, if there was one). TcPO2 was
measured with a polarographic electrode (Micro Gas
7640, Kontron instruments) heated at 458. CalibrationEur J Vasc Endovasc Surg Vol 31, 3 2006for atmospheric pressure was made before each
measurement. A direct reading in mmHg was taken
after a perfect stabilisation of the TcPO2 (mean
duration of the procedure was 30 min).Measurement by pole test
Measurement of pressures after 30 min in the supine
position by insonating (8 MHz probe) the three ankle
arteries (dorsalis pedis, posterior tibial and peroneal
artery) and the hallux collateral artery, with a
calibrated pole (zero pressure level being situated at
the level of the left ventricle and corresponding to the
anterior axillary line in a supine position). The foot
was slowly elevated until the disappearance of systolic
pressure signal. The height at which the signal
disappeared corresponded to the systolic pressure in
cmH2O and was transformed to mmHg (13 cmH2OZ
10 mmHg). This procedure was repeated three times
for each artery. The mean value of each artery was
noted and the highest mean value was used. Intra-
observer variability was good, for highest measure-
ments mean standard deviation was 0.7 mmHg (range
0–5). Inter-observer variability was not assessed.Measurement by cuff-manometry
After 30 min in the supine position, measurement of
arterial systolic pressures of the same four arteries,
using a 15 cm wide cuff placed just above the malleoli
and a 8 MHz Doppler probe. This procedure also was
repeated three times for each artery and the highest
mean value was used.Arteriography
All patients had an arteriographic examination.
Measurements of blood pressures derived from cuff-
manometry and pole test were not feasible in some
patients’ limbs because of incompressibility of arterial
walls and limited maximal leg elevation. If ASP was O
200 mmHg and or a persistent Doppler signal at
maximal leg elevation occurred in the pole test were,
limbs were excluded from statistical analysis (for
comparisons and correlations). We also decided to
include diabetic and long term renal dialysis patients in
a single group, since both have arterial wall stiffness.Analysis
Comparisons between the three different non-invasive
methods were made with rank sum two-sample test
Table 1. Patient characteristic
All patients Patients with
diabetes
Patients without
diabetes
Number of
patients
74 Type I: 26 35
Type II: 13
Number of
limbs
83 Type I: 27 41
Type II: 15
Sex ratio m/f 58/16 28/11 30/5
Mean age
(years)
72.57 (31–92) 75.62 68.93
Smoking 46/74 20/74 26/74
Hypertension 44/74 22/74 22/74
Dyslipidemia 8 patients 4 4
On dialysis 13 patients
(16 legs)
7 patients
(8 legs)
6 patients
(8 legs)
Rest pain 17 legs 4 legs 13 legs
Foot ulcers/
gangrene
66 legs 38 legs 28 legs
Pole Test in Critical Leg Ischaemia 255(Mann–Whitney). Correlations were obtained by
linear regression. The r coefficient of linear correlation
which is the measurement of the intensity of a linear
relation between two diagnostic tests was calculated;
p values!0.05 were regarded as significant. Sensi-
tivity, specificity, predictive values and accuracy were
carried out for the evaluation of the pole test. ROC
curves were used for the optimum cut-off value of the
pole test for the detection of CLI. Finally, intra-
observer variability of the pole test measurements
was assessed.Results
The demographic details of the patients are shown in
Table 1. For the 57 legs considered to have CLI, 51 had
cuff-manometry measurements and 54 pole test
measurements. TcPO2 was obtained for all limbs.
Forty-eight limbs were evaluated by both cuff-
manometry and pole test, 51 by cuff-manometry and
TcPO2 and 54 by pole test and TcPO2. Forty-eight limbs
were evaluated by all three methods.
Comparisons between measurements obtained by
sphygmomanometry and pole test are shown in
Table 2.
Mean TcPO2 value was 15.51 (SDG14.18, nZ57)
and there was no difference between patients withTable 2. Comparison between patients with and without diabetes fo
All patients
(meanGSD, number)
With diabetes
(meanGSD, num
Cuff-pressure (mmHg) 66.76G35.51, nZ51 80G38.49, nZ23
Pole pressure (mmHg) 26.76G12.88, nZ54 29.27G12.61, nZ
Pressure difference
(mmHg)
40 50.73
p !0.001 !0.001diabetes (12.68G12.43, nZ28) and those without
diabetes (18.24G15.40, nZ29), pZ0.210.
Correlations between the three tests are shown in
Table 3. There was a significant correlation between
sphygmomanometry and pole test measurements (rZ
0.481).
No correlation was found between cuff-manometry
and pole test for patient with diabetes. However, there
was a correlation between these two tests for patients
without diabetes (rZ0.581). No correlation was
observed between sphygmomanometry measure-
ments and TcPO2. A correlation was found between
pole test and TcPO2 measurements only for patients
with diabetes (rZ0.444).
According to our definition of CLI, from the 83
lower limbs assessed in our study, only 57 were
classified as having CLI. We used the same definition
as a gold standard for the evaluation of the pole test.
From ROC curves, the optimum cut-off value of the
pole test for the detection of CLI was of 50 mmHg
(Fig. 1). The pole test when used alone to detect CLI
showed a sensitivity of 94.7%, a specificity of 73.1%, a
positive predictive value (PPV) of 88.5% and a
negative predictive value (NPV) of 86.4%. The
accuracy of the test was of 88.0%. These values are
given in Table 4.Discussion
All pressures measured by sphygmomanometry were
higher than those obtained by leg elevation in the pole
test. This finding is in keeping with other authors.15,16
Pressures measured by both cuff-manometry and
pole test were higher in patients with diabetes than in
those without diabetes and these differences were
statistically significant. The difference between the two
methods was significantly greater for those with
diabetes than for those without. Although, Smith15
showed a similar trend, his data did not achieve
statistical significance.
In the study by Smith15 all patients investigated
were assessed by pole test at the ankle level and no
patient had a persistent Doppler signal at maximal leg
elevation. On the contrary, Pahlsson et al.6 found, thatr cuff-manometry and pole test measurements (legs in CLI)
ber)
Without diabetes
(meanGSD, number)
Pressure
difference
p
55.89G29.25, nZ28 24.11 !0.001
26 24.43G12.91, nZ28 4.84 !0.05
31.46
!0.001
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Table 3. Correlations between the three tests (legs in CLI)
r p n Excluded
Cuff-pressure and pole test
All patients 0.481 !0.001 48 9
With diabetes 0.344 0.131 21 7
Without diabetes 0.583 !0.005 27 2
Cuff-pressure and TcPO2
All patients 0.000 0.999 51 6
With diabetes 0.022 0.921 23 5
Without diabetes 0.118 0.552 28 1
Pole test and TcPO2
All patients 0.208 0.132 54 3
With diabetes 0.444 !0.05 26 2
Without diabetes 0.09 0.630 28 1
Table 4. Evaluation of the pole test in the detection of CLI
CLI/non-CLI Pole test %50 mmHg
Sensitivity 94.7
Specificity 73.1
False-negatives 5.3
False-positives 26.9
PPV 88.5
NPV 86.4
Accuracy 88.0
N. Paraskevas et al.256at ankle level, the pole test provided a pressure
measurement in less than half (42%) of legs: the
remaining 58% had a persistent Doppler signal: this
was attributed to the varying inclusion criteria. In our
study, pole test measurements were possible in 62/83
legs (when we include all stage III and IV limbs).
When we considered only limbs with CLI, the pole test
measurements were attained from 54/57 legs.
The value of the pole test in the diagnosis of severe
ischaemia is limited by lower leg length. The leg length
of most patients does not permit pressures greater
than 45 mmHg6–60 mmHg15,17 to be measured at the
ankle level. At the toe level higher pressures
(55–70 mmHg6,17) can be measured because the
distance from the hip to the toe is longer. In our
study, we managed to measure pole test pressures as
high as 70 mmHg but in many patients, because of the
limited leg length or mobility in the elderly, values
greater than 50 mmHg could not be measured.
There was a good correlation between sphygmo-
manometry and pole test measurements for patients
without diabetes but there was no correlation for
patients with diabetes. This is similar to the findings of0
0.2
0.4
0.6
0.8
1
se
n
sit
iv
ity
0 0.2 0.4 0.6 0.8 1
1-specificity
Area under ROC curve : 0.86 (0.77 – 0.96)
20
10
30
40
50
Fig. 1. ROC analysis of different cut-off values of pole test
measurements (in mmHg) for the detection of critical limb
ischaemia.
Eur J Vasc Endovasc Surg Vol 31, 3 2006Jachertz16 who found a better correlation between the
two tests for patients without diabetes.
There is controversy about the influence of medial
calcification on TcPO2 measurements.
18,19 Like Wyss
et al.19 we did not find any statistical difference
between TcPO2 measurements in patients with and
without diabetes. Wyss et al.20 suggested that TcPO2
and Ankle–brachial pressure measurements yield
similar results for haemodynamic outcomes in
patients without diabetes and in diabetics without
important calcification, but our data, like those of
Jachertz,16 did not show a correlation between TcPO2
and cuff-manometry for either group of patients.
Nevertheless we found a correlation between pole
test measurements and TcPO2 in patients with
diabetes. Perhaps this results from the fact that
TcPO2 depends on the microcirculation, which is
influenced by diabetic microangiopathy.21,22 However,
Jachertz16 found a good correlation between the two
tests for patients without diabetes.
The pole test was evaluated in this study as a
diagnostic test for CLI. Our study showed that the pole
test was very accurate, with high sensitivity and high
NPV for the detection of CLI. It also had good
specificity and a high PPV. However, further work
remains to assess the inter-observer variability of pole
test measurements and the reproducibility of this test
in different settings.
It is well-known sphygmomanometry is very
specific for the detection of CLI but has a low
sensitivity and a large number of false-negatives.23
This is because critical ischaemia can exist with high
ankle pressures especially in patients with stiff arteries
(those with diabetes or on renal dialysis).
Transcutaneous oximetry is used regularly for
the detection of CLI but its reproducibility13,14 and
accuracy23 have been questioned. Furthermore, there
is a big variation in the cut-off values proposed by
different authors.2,3,23,24
The assessment of critical ischaemia by means of
non-invasive measurements can probably be
improved by the combination of several techniques.
The pole test could play an important role in
Pole Test in Critical Leg Ischaemia 257the detection of CLI especially in patients presenting
calcified incompressible leg arteries.Acknowledgements
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